Stay updated on INTRINSIC Clinical Trial: Tailored Metastatic CRC Therapies
Sign up to get notified when there's something new on the INTRINSIC Clinical Trial: Tailored Metastatic CRC Therapies page.

Latest updates to the INTRINSIC Clinical Trial: Tailored Metastatic CRC Therapies page
- Check5 days agoChange DetectedNew trial sites have been added, expanding the study's locations to 82 with entries in Illinois, Texas, Spain, Tennessee, and other regions. The page now reflects broader site coverage and notes Withdrawn statuses for some locations.SummaryDifference0.7%

- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedThe page's revision label was updated from v3.5.3 to v3.5.4, indicating a new revision was saved. This appears to be a minor, internal update rather than a change to visible content or functionality.SummaryDifference0.0%

- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedTwo new recruitment sites were added: Uniwersyteckie Centrum Kliniczne, O?rodek Bada? Klinicznych Wczesnych Faz in Gdańsk, Poland, and IRST - PPDS in Meldola, Emilia-Romagna, Italy, expanding the study's geographic footprint. The page now indicates 76 locations.SummaryDifference0.3%

- Check40 days agoChange DetectedThe page’s revision version label was updated from v3.5.2 to v3.5.3, indicating an internal update to the ClinicalTrials.gov page build rather than a change to the study record content.SummaryDifference0.0%

- Check47 days agoChange DetectedRevision: v3.5.2 was added and Revision: v3.5.0 was removed.SummaryDifference0.0%

- Check61 days agoChange DetectedAdded Hospital Universitario Puerta de Hierro - Majadahonda in Madrid as a recruiting site, bringing the total locations to 74. Updated the Padova site spelling from Padua to Padova and adjusted recruitment statuses across locations to reflect current activity.SummaryDifference0.3%

Stay in the know with updates to INTRINSIC Clinical Trial: Tailored Metastatic CRC Therapies
Enter your email address, and we'll notify you when there's something new on the INTRINSIC Clinical Trial: Tailored Metastatic CRC Therapies page.